On July 26, 2021, Jitsubo received ISO27001 certification, an international standard for Information Security Management Systems (ISMS) that covers the development and operation of information assets and internal systems.
|Certifications of Standards||ISO/IEC 27001：2013 （JIS Q 27001：2014）|
|Scope of Certification||Management business limited to specific fields in contractwork related to peptide synthesis|
|Approval Date||July 26, 2021|
With this certification, we will establish a high-level information management system that fully meets global standards, and we will continue to maintain and improve our information security management to provide services that earn the trust of our customers.
IWAKI & CO., LTD., a leading specialized pharmaceutical trading company, has announced today its acquisition of Jitsubo CO., LTD., a pharmaceutical venture with unique liquid phase peptide manufacturing technology, Molecular Hiving™, through its 100% subsidiary, SPERA PHARMA, Inc. a CMC R&D contract company. With this transaction, Jitsubo has become 100% subsidiary of SPERA PHARMA.
Bubendorf/Basel, Switzerland and Yokohama, Japan, May 8, 2020 – Bachem (SIX: BANB) and Jitsubo CO., LTD. announce today that they signed an exclusive Licensing Agreement for Jitsubo’s Molecular Hiving™ technology. Under the License agreement, Jitsubo will develop selected manufacturing processes using their Molecular Hiving™ technology and transfer these processes to Bachem. Bachem will further optimize, scale up and produce for commercial applications. In return, Jitsubo will receive development fees and royalties.
Coments of Kazuaki Kanai CEO, appeared in the e-book of Agilent Technologies, Inc
We will give a poster presentation at 10th International Peptide Symposium in Kyoto on the 5th December.
◆Schedule : 13:10 – 14:10, Wednesday 5th, December
For more ditails, please visit the official site;
We are looking forward to seeing you.
EuroPEPTIDES：Part of TIDES Europe 2018
◆Date：November 7th-8th 2018（Exhibition)
◆Place：Postillion Convention Center, Amsterdam, Netherlands
◆Speaker：CEO Kazuaki Kanai Ph.D.
◆Title ：Cost-Efficient Manufacturing Procedure of Peptide using Molecular Hiving™ Technology
◆Schedule：Thursday 8th 11:30～
For further details, please visit website.
We look forward to seeing you at EuroPEPTIDES.